Skip to Main Navigation

National Health Insurance (JKN) Reforms and Results Program

Abstract*

The development objective of the National Health Insurance (JKN) Reforms and Results Program for Indonesia is to strengthen the quality and efficiency of Indonesia’s JKN program. The program-for-results (PforR) focuses on reforms to improve the quality and efficiency of JKN. Activities are organized around three results area (RAs). RA 1 aims to strengthen the quality of care; RA 2 aims to improve the efficiency of JKN spending; and RA 3 is cross-cutting...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The program development objective is to strengthen the quality and efficiency of Indonesia's National Health Insurance program.

Key Details

Project Details

  • P172707

  • Active

  • Zelalem Debebe , Eko Pambudi, Somil Nagpal

  • Republic of Indonesia

  • Indonesia

  • July 12, 2020

  • (as of board presentation)

    December 15, 2021

  • May 17, 2022

  • US$ 18752.33 million

  • BPJS- Kesehatan,Ministry of Health,Dewan Jaminan Sosial Nasional (DJSN),Ministry of Finance

  • East Asia and Pacific

  • 2022

  • US$ 402.33 million

  • N/A

  • June 13, 2024

  • September 30, 2026

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
International Bank for Reconstruction and Development 400.00
Indonesia - Free-standing Trust Fund Program 2.33

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 400.00
IDA Commitment N/A
IBRD + IDA Commitment 400.00
Lending Instrument
Grant Amount 2.33
Total Project Cost** 18752.33

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Feb 1, 2024 IBRD-93160 Int Charges 3,218,669.00
Aug 1, 2024 IBRD-93160 Int Charges 4,660,697.50
Aug 1, 2024 IBRD-93160 Int Charges 20,688.06
Aug 1, 2024 IBRD-93160 Int Charges 317,818.06
Jul 28, 2022 IBRD-93160 Loan Disb 100,000,000.00
Jul 16, 2022 IBRD-93160 Fee Charges 1,000,000.00
Feb 1, 2023 IBRD-93160 Int Charges 378,082.20
Feb 1, 2023 IBRD-93160 Int Charges 2,185,289.20
Aug 1, 2023 IBRD-93160 Int Charges 85,413.71
Aug 1, 2023 IBRD-93160 Int Charges 371,917.80
Aug 1, 2023 IBRD-93160 Int Charges 2,754,628.00
Feb 1, 2023 IBRD-93160 Int Charges 41,095.89
Feb 1, 2023 IBRD-93160 Int Charges 38,251.57
Feb 1, 2024 IBRD-93160 Int Charges 23,313.11
Feb 1, 2024 IBRD-93160 Int Charges 377,908.16
Dec 15, 2021 IBRD-93160 Loan Commitment 400,000,000.00
Feb 27, 2024 IBRD-93160 Loan Disb 51,740,000.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Monitoring and Evaluation Moderately Satisfactory 2024-12-20
Monitoring and Evaluation Satisfactory 2024-12-20
Overall Implementation Progress (IP) Satisfactory 2024-12-20
Progress towards achievement of PDO Moderately Satisfactory 2024-12-20
Overall Implementation Progress (IP) Moderately Satisfactory 2024-12-20
Progress towards achievement of PDO Moderately Satisfactory 2024-12-20

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Increase in the % of outpatient utilization among bottom two quintilesValue13.208.5015.20
    DateDecember 31, 2019March 31, 2023December 31, 2026
    Comment
  • Improved provider competency score in FKTPsValueTo be determined in 2024Not yet determinedIncreased above baseline values for at least 70 pe
    DateDecember 31, 2024May 27, 2024December 31, 2026
    Comment
  • More sustainable claims ratioValue102%105%<98%
    DateDecember 31, 2019December 29, 2023December 31, 2026
    Comment
  • Improved member satisfaction rate and its continued use as a BPJS-K performance monitoring indicatorValue81.5%89.6%Above 82%(and continued as BPJS performance indic
    DateDecember 31, 2019December 30, 2022December 31, 2026
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Decrease in the % of claims that were pending settlement for more than 14 daysValue2.57To be determinedTo be determined
    DateJune 30, 2023December 19, 2023December 31, 2026
    Comment
  • Improved policy formulation and oversight of JKNValueNA0Annual report for previous year published
    DateOctober 1, 2021May 31, 2024December 31, 2026
    Comment
  • Number of clinical diagnostic, treatment, or referral guidelines formulated into processes of care for FKRTLsValue0.0010.0020.00
    DateOctober 1, 2021May 31, 2024December 31, 2026
    Comment
  • Number of additional performance and quality indicators included in primary care payment systemValue3.003.0013.00
    DateOctober 1, 2021May 31, 2024December 31, 2026
    Comment
  • Increase in the % of antenatal care visits in-line with clinical protocols disaggregated by provinceValueBaseline in Year 2024Delayed due to DLI 1. Baseline in Year 2024To be determined
    DateDecember 19, 2023May 31, 2024December 31, 2026
    Comment
  • Cumulative number of FKRTLs with trained and certified clinical codersValue0.00567.001800.00
    DateOctober 1, 2021January 31, 2024December 31, 2026
    Comment
  • Number of maternal deaths caused by hypertension disaggregated by provinceValue10661010<900
    DateOctober 1, 2021December 29, 2023December 31, 2026
    Comment
  • Increase in the % of adults screened for diabetes and hypertension in-line with clinical protocolsValueBaseline in year 2024Delayed due to DLI 1. Baseline in Year 2024To be determined
    DateDecember 31, 2024May 31, 2024December 31, 2026
    Comment
  • Improved provider competency on maternal care disaggregatedValueBaseline to be determinedNot yet due. DLI 1 linked. Baseline to be determinThe competence scores are increased for at least 7
    DateDecember 31, 2024May 31, 2024December 31, 2026
    Comment
  • Recommended tracer indicators embedded and automated in the claims verification software to monitor compliance with evidence-based careValue0Delayed due to DLI 1 &2 25 (15 for FKTP and 10 for FKRTL)
    DateOctober 1, 2021May 31, 2024December 31, 2026
    Comment
  • Number of information systems integrated as per roadmap targetValue03To be determined by roadmap
    DateOctober 1, 2021May 31, 2024December 31, 2026
    Comment
  • Share of FKTPs trained in using the clinical decision support toolValue0.000.0090.00
    DateOctober 1, 2021May 31, 2024December 31, 2025
    Comment